Stocks and Investing Stocks and Investing
Fri, May 8, 2015
Thu, May 7, 2015
Wed, May 6, 2015
Tue, May 5, 2015
Mon, May 4, 2015
Fri, May 1, 2015
Thu, April 30, 2015
Wed, April 29, 2015
Tue, April 28, 2015
Mon, April 27, 2015
Fri, April 24, 2015
Thu, April 23, 2015

Matthew Luchini Initiated (BLUE) at Buy and Held Target at $160 on, Apr 23rd, 2015


Published on 2024-10-25 08:27:35 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $160 on, Apr 23rd, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Initiated at Strong Buy and Held Target at $190 on, Wednesday, April 22nd, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $117 on, Thursday, February 26th, 2015